Find cutting edge cancer clinical trials near you using the new Victorian Cancer Trials Link.

Search now

Peer-reviewed epidemiology journal articles 2005

Breast Cancer

Baglietto L, English DR, Gertig DM, Hopper JL, Giles GG. Does dietary folate intake modify effect of alcohol consumption on breast cancer risk? Prospective cohort study. BMJ. 2005;331:807

Chang JH, Gertig DM, Chen X, Dite GS, Jenkins MA, Milne RL, Southey MC, McCredie MR, Giles GG, Chenevix-Trench G, Hopper JL, Spurdle AB. CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study. Breast Cancer Res. 2005;7:R513-521

Chenevix-Trench G, Sinilnikova OM, Suthers G, Pandeya N, Mazoyer S, Sambrook JF, Goldup S, Goldgar D, Lynch HT, Lenoir GM, Cheetham G, kConFab. Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers. Fam Cancer. 2005;4:73-75

Dite GS, Wark JD, Giles GG, English DR, McCredie MR, Hopper JL. Is there overlap between the genetic determinants of mammographic density and bone mineral density? Cancer Epidemiol Biomarkers Prev. 2005;14:2266-2268

Hopper JL, Hayes VM, Spurdle AB, Chenevix-Trench G, Jenkins MA, Milne RL, Dite GS, Tesoriero AA, McCredie MR, Giles GG, Southey MC. A protein-truncating mutation in cyp17a1 in three sisters with early-onset breast cancer. Hum Mutat. 2005;26:298-302

Jekimovs CR, Chen X, Arnold J, Gatei M, Richard DJ, Spurdle AB, Khanna KK, Chenevix-Trench G, kConFab I. Low frequency of chek2 1100delc allele in Australian multiple-case breast cancer families: Functional analysis in heterozygous individuals. Br J Cancer. 2005;92:784-790

Kavanagh AM, Cawson J, Byrnes GB, Giles GG, Marr G, Tong B, Gertig DM, Hopper JL. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography. Cancer Epidemiol Biomarkers Prev. 2005;14:1060-1064

Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD. Common polymorphisms in ERCC2 (xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:1828-1831

Lewis AG, Flanagan J, Marsh A, Pupo GM, Mann G, Spurdle AB, Lindeman GJ, Visvader JE, Brown MA, Chenevix-Trench G, Kathleen Cuningham Foundation Consortium for Research into Familial Breast C. Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer. Breast Cancer Res. 2005;7:R1005-1016

Loi S, Milne RL, Friedlander ML, McCredie MR, Giles GG, Hopper JL, Phillips KA. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:1686-1691

Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2005;14:350-356

Montgomery KG, Chang JH, Gertig DM, Dite GS, McCredie MR, Giles GG, Southey MC, Hopper JL, Campbell IG. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women. Breast Cancer Res. 2005;7:R353-356

Orlando L, Renne G, Rocca A, Curigliano G, Colleoni M, Severi G, Peruzzotti G, Cinieri S, Viale G, Sanna G, Goldhirsch A. Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotype. Ann Oncol. 2005;16:1094-1099

Phelan CM, Dapic V, Tice B, Favis R, Kwan E, Barany F, Manoukian S, Radice P, van der Luijt RB, van Nesselrooij BP, Chenevix-Trench G, kConFab, Caldes T, de la Hoya M, Lindquist S, Tavtigian SV, Goldgar D, Borg A, Narod SA, Monteiro AN. Classification of BRCA1 missense variants of unknown clinical significance. J Med Genet. 2005;42:138-146

Phillips KA, Butow PN, Stewart AE, Chang JH, Weideman PC, Price MA, McLachlan SA, Lindeman GJ, McKay MJ, Friedlander ML, Hopper JL, kConFab I. Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. Fam Cancer. 2005;4:105-113

Phillips KA, Milne RL, Buys S, Friedlander ML, Ward JH, McCredie MR, Giles GG, Hopper JL. Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry. J Clin Oncol. 2005;23:4679-4686

Southey MC, Jenkins MA, Mead L, Whitty J, Trivett M, Tesoriero AA, Smith LD, Jennings K, Grubb G, Royce SG, Walsh MD, Barker MA, Young JP, Jass JR, St John DJ, Macrae FA, Giles GG, Hopper JL. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol. 2005;23:6524-6532

Spurdle AB, Antoniou AC, Duffy DL, Pandeya N, Kelemen L, Chen X, Peock S, Cook MR, Smith PL, Purdie DM, Newman B, Dite GS, Apicella C, Southey MC, Giles GG, Hopper JL, Chenevix-Trench G, Easton DF. The androgen receptor cag repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res. 2005;7:R176-183

Tesoriero AA, Wong EM, Jenkins MA, Hopper JL, Brown MA, Chenevix-Trench G, Spurdle AB, Southey MC, kConFab. Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple-case breast cancer families. Hum Mutat. 2005;26:495

Thompson D, Antoniou AC, Jenkins M, Marsh A, Chen X, Wayne T, Tesoriero A, Milne R, Spurdle A, Thorstenson Y, Southey M, Giles GG, Khanna KK, Sambrook J, Oefner P, Goldgar D, Hopper JL, Easton D, Chenevix-Trench G. Two ATM variants and breast cancer risk. Hum Mutat. 2005;25:594-595

Wardrop SL, Brown MA, kConFab I. Identification of two evolutionarily conserved and functional regulatory elements in intron 2 of the human BRCA1 gene. Genomics. 2005;86:316-328

Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB. Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:319-323

Woodward AM, Davis TA, Silva AG, Kirk JA, Leary JA, kConFab I. Large genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected families. J Med Genet. 2005;42:e31

Colorectal Cancer

Haydon A, Macinnis RJ, English D, Giles GG. Usual diet before diagnosis and survival from colorectal cancer. Asia-Pacific Journal of Clinical Oncology. 2005;1:98-104

Prostate Cancer

Hayes VM, Severi G, Eggleton SA, Padilla EJ, Southey MC, Sutherland RL, Hopper JL, Giles GG. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev. 2005;14:993-996

Hayes VM, Severi G, Padilla EJ, Eggleton SA, Southey MC, Sutherland RL, Hopper JL, Giles GG. Genetic variants in the vitamin d receptor gene and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:997-999

Hope Q, Bullock S, Evans C, Meitz J, Hamel N, Edwards SM, Severi G, Dearnaley D, Jhavar S, Southgate C, Falconer A, Dowe A, Muir K, Houlston RS, Engert JC, Roquis D, Sinnett D, Simard J, Heimdal K, Moller P, Maehle L, Badzioch M, Eeles RA, Easton DF, English DR, Southey MC, Hopper JL, Foulkes WD, Giles GG. Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005;14:397-402

Horninger W, Berger A, Pelzer A, Klocker H, Oberaigner W, Schonitzer D, Severi G, Robertson C, Boyle P, Bartsch G. Screening for prostate cancer: Updated experience from the tyrol study. Can J Urol. 2005;12 Suppl 1:7-13; discussion 92-13

Schaid DJ, Chang BL. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13. The Prostate. 2005;63:276-290

Xu J, Dimitrov L, Chang BL, et al. A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the International Consortium for Prostate Cancer Genetics (ICPCG). Am J Hum Genet. 2005;77:219-229

Melanoma

Autier P, Severi G, Boniol M, de Vries E, Coebergh JW, Dore JF. Re: Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:1159; author reply 1159-1160

Banky JP, Kelly JW, English DR, Yeatman JM, Dowling JP. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol. 2005;141:998-1006

Bataille V, Boniol M, De Vries E, Severi G, Brandberg Y, Sasieni P, Cuzick J, Eggermont A, Ringborg U, Grivegnee AR, Coebergh JW, Chignol MC, Dore JF, Autier P. A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe. Eur J Cancer. 2005;41:2141-2149

de Vries E, Boniol M, Severi G, Eggermont AM, Autier P, Bataille V, Dore JF, Coebergh JW. Public awareness about risk factors could pose problems for case-control studies: The example of sunbed use and cutaneous melanoma. Eur J Cancer. 2005;41:2150-2154

English DR, Milne E, Jacoby P, Giles-Corti B, Cross D, Johnston R. The effect of a school-based sun protection intervention on the development of melanocytic nevi in children: 6-year follow-up. Cancer Epidemiol Biomarkers Prev. 2005;14:977-980

English DR, Milne E, Simpson JA. Sun protection and the development of melanocytic nevi in children. Cancer Epidemiol Biomarkers Prev. 2005;14:2873-2876

Other Cancer

Frydenberg M, Millar JL, Toner G, Bolton D, Syme R, Thursfield VJ, Giles GG. Management of superficial bladder cancer in Victoria: 1990 and 1995. ANZ J Surg. 2005;75:270-274

MacInnis RJ, English DR, Hopper JL, Giles GG. Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst. 2005;97:1154-1157

Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J, Arslan A, Ahlbom A, Giles GG, Howe GR, Menegoz F, Rodvall Y, Choi WN, Wahrendorf J. Occupational risk factors for low grade and high grade glioma: Results from an international case control study of adult brain tumours. Int J Cancer. 2005;113:116-125

Serrano D, Baglietto L, Johansson H, Mariette F, Torrisi R, Onetto M, Paganuzzi M, Decensi A. Effect of the synthetic retinoid fenretinide on circulating free prostate-specific antigen, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 levels in men with superficial bladder cancer. Clin Cancer Res. 2005;11:2083-2088

Simpson JA, MacInnis RJ, English DR, Gertig DM, Morris HA, Giles GG. A comparison of estradiol levels between women with a hysterectomy and ovarian conservation and women with an intact uterus. Climacteric. 2005;8:300-303

Other Conditions

Asia Pacific Cohort Studies Collaboration. Joint effects of systolic blood pressure and serum cholesterol on cardiovascular disease in the Asia Pacific region. Circulation. 2005;112:3384-3390

Barzi F, Patel A, Woodward M, Lawes CM, Ohkubo T, Gu D, Lam TH, Ueshima H. A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region. Ann Epidemiol. 2005;15:405-413

Feigin V, Parag V, Lawes CM, Rodgers A, Suh I, Woodward M, Jamrozik K, Ueshima H. Smoking and elevated blood pressure are the most important risk factors for subarachnoid hemorrhage in the Asia-Pacific region: An overview of 26 cohorts involving 306,620 participants. Stroke. 2005;36:1360-1365

Flicker L, MacInnis RJ, Stein MS, Scherer SC, Mead KE, Nowson CA, Thomas J, Lowndes C, Hopper JL, Wark JD. Should older people in residential care receive vitamin d to prevent falls? Results of a randomized trial. J Am Geriatr Soc. 2005;53:1881-1888

Huxley R, Barzi F, Stolk R, Caterson I, Gill T, Lam TH, Omari A, Woodward M. Ethnic comparisons of obesity in the Asia-Pacific region: Protocol for a collaborative overview of cross-sectional studies. Obes Rev. 2005;6:193-198

Huxley R, Woodward M, Barzi F, Wong JW, Pan WH, Patel A. Does sex matter in the associations between classic risk factors and fatal coronary heart disease in populations from the Asia-Pacific region? J Womens Health (Larchmt). 2005;14:820-828

Lee CT, Rowley K, Jenkins AJ, O'Dea K, Itsiopoulos C, Stoney RM, Su Q, Giles GG, Best JD. Paraoxonase activity in Greek migrants and Anglo-Celtic persons in the Melbourne Collaborative Cohort Study: Relationship to dietary markers. Eur J Nutr. 2005;44:223-230

Mishra G, Ball K, Patterson A, Brown W, Hodge A, Dobson A. Socio-demographic inequalities in the diets of mid-aged Australian women. Eur J Clin Nutr. 2005;59:185-195

Pigatto PD, Guzzi G, Severi G. Oral lichen planus: Mercury and its kin. Arch Dermatol. 2005;141:1472-1473; author reply 1473

Woodward M, Huxley H, Lam TH, Barzi F, Lawes CM, Ueshima H. A comparison of the associations between risk factors and cardiovascular disease in Asia and Australasia. Eur J Cardiovasc Prev Rehabil. 2005;12:484-491

Woodward M, Lam TH, Barzi F, Patel A, Gu D, Rodgers A, Suh I. Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol. 2005;34:1036-1045

Scientific Methods

Coyne T, Ibiebele TI, McNaughton S, Rutishauser IH, O'Dea K, Hodge AM, McClintock C, Findlay MG, Lee A. Evaluation of brief dietary questions to estimate vegetable and fruit consumption - using serum carotenoids and red-cell folate. Public Health Nutr. 2005;8:298-308

Giles GG. Medical record linkage in Australia: This is as good as it gets. ANZ J Surg. 2005;75:259